Bristol-Myers Squibb Company is a large biopharmaceutical company. Its filings show it lobbied Congress about health issues, including education on the value of biopharmaceutical innovation and related topics. The company used the firm W Strategies, LLC for lobbying. The filing reported no spending.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DARREN WILLCOX
The latest disclosures for this client.
W STRATEGIES, LLC
Q1W STRATEGIES, LLC
RRThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
W STRATEGIES, LLC